Sarah Teichmann is a Professor of Stem Cell Medicine at the University of Cambridge who conducted research at the Early Cancer Institute.
Referenced in coverage
“Founding co-chair of Human Cell Atlas commenting on GPT-Rosalind agents analyzing biological data.”